Target intelligence / Profile preview

BPI fold containing family A member 2 (BPIFA2)

Target
BPIFA2
Molecular classification
Secreted protein, Member of BPI/LBP/PLUNC superfamily, Bactericidal/permeability-increasing fold protein, Lipid-binding protein, Salivary surfactant
01

Overview

BPI fold containing family A member 2 (BPIFA2) is a secreted protein highly expressed in the "parotid (salivary) gland" and also present in the oropharyngeal mucosa. BPIFA2 belongs to the BPI/LBP/PLUNC superfamily, defined by the bactericidal/permeability-increasing protein fold. Its functions include binding "lipopolysaccharide (LPS)", acting as a salivary surfactant to lower saliva surface tension, promoting agglutination and clearance of bacteria, and contributing to the first line of mucosal defense in the oral cavity. Mouse models lacking BPIFA2 show increased sensitivity to ingested LPS, resulting in mild metabolic endotoxemia, increased insulin secretion, and metabolomic changes, underscoring a link between "oral defense and systemic metabolic regulation". BPIFA2 autoantibodies have been detected in Sjögren’s syndrome, suggesting a potential disease association. Synthetic peptides based on BPIFA2 structure (e.g., GL13NH2, GL13K) exhibit antimicrobial and anti-inflammatory properties, but BPIFA2 itself is not a direct drug target.

Other names
BPIFA2C20orf70Parotid secretory proteinPSPSPLUNC2bA49G10.1Short palate, lung and nasal epithelium carcinoma-associated protein 2
02

Biological functions

Antibacterial activity (agglutination/inhibition of bacterial growth)Lipopolysaccharide (LPS) bindingSalivary surfactant (lowers saliva surface tension)Host defense at oral mucosal surfacesPotential regulation of epithelial sodium channelsLipid binding and transport
03

Disease associations

Mild inflammation, including endotoxemia due to altered LPS activityPossible metabolic effects (e.g., altered insulin secretion, involvement in metabolic syndrome)Potentially involved in Sjögren’s syndrome (autoantibodies to BPIFA2 detected in some patients and mouse models)No direct evidence for roles in cancer, neurodegeneration, or cardiovascular disease
04

Biomarkers

Anti-BPIFA2 autoantibodies (potential biomarker for Sjögren’s syndrome)BPIFA2 protein levels in saliva (potential biomarker for mucosal health or inflammation)

Beyond the preview

Go deeper on BPI fold containing family A member 2 (BPIFA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BPI fold containing family A member 2 (BPIFA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call